FGFR2 risk SNPs confer breast cancer risk by augmenting oestrogen responsiveness

The fibroblast growth factor receptor 2 (FGFR2) locus is consistently the top hit in genome-wide association studies for oestrogen receptor-positive (ER(+)) breast cancer. Yet, its mode of action continues to be controversial. Here, we employ a systems biology approach to demonstrate that signalling...

Descripción completa

Detalles Bibliográficos
Autores principales: Campbell, Thomas M., Castro, Mauro A.A., de Santiago, Ines, Fletcher, Michael N.C., Halim, Silvia, Prathalingam, Radhika, Ponder, Bruce A.J., Meyer, Kerstin B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Original Manuscript
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967216/
https://www.ncbi.nlm.nih.gov/pubmed/27236187
http://dx.doi.org/10.1093/carcin/bgw065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967216/
https://www.ncbi.nlm.nih.gov/pubmed/27236187
http://dx.doi.org/10.1093/carcin/bgw065

Ejemplares similares